Flavonoids: biochemical effects and therapeutic applications

Rusniyak, 1936, Vitamin P: flavonols as vitamins, Nature, 138, 27, 10.1038/138027a0 Kohrle, 1986, Iodothyronine deiodinase is inhibited by plant flavonoids, 359 Hartman, 1990, Antimutagens and anticarcinogens: a survey of putative interceptor molecules, Environ Mol Mutagenesis, 15, 145, 10.1002/em.2850150305 Moroney, 1988, Selectivity of neutrophil 5-lipoxygenase and cyclo-oxigenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids, J Pharm Pharmacol, 40, 782, 10.1111/j.2042-7158.1988.tb05173.x Alcaraz, 1987, Modification of arachidonic acid metabolism by flavonoids, Ethnopharmacol, 21, 209, 10.1016/0378-8741(87)90101-2 Mathew, 1955, Inhibition of hyaluronidase, Physiol Rev, 35, 381, 10.1152/physrev.1955.35.2.381 Kakegawa, 1988, Inhibitory effects of hydrangenol derivatives on the activation of hyaluronidase and their antiallergic activities, Planta Medica, 54, 385, 10.1055/s-2006-962477 Cameron, 1979, Ascorbic acid and cancer: a review, Cancer Res, 39, 663 Meyer, 1947, The biological significance of hyaluronic acid and hyaluronidase, Physiol Rev, 27, 335, 10.1152/physrev.1947.27.3.335 Kuppusamy, 1990, Structure-activity studies of flavonoids as inhibitors of hyaluronidase, Biochem Pharmacol, 40, 397, 10.1016/0006-2952(90)90709-T Mora, 1990, Structure-activity relationship of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxydation, Biochem Pharmacol, 40, 793, 10.1016/0006-2952(90)90317-E Jha, 1985, Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids, Biochem Pharmacol, 34, 1367, 10.1016/0006-2952(85)90672-0 Ferrell, 1979, Structure/activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices, Mol Pharmacol, 16, 556 Beretz, 1978, Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase, Experientia, 34, 1054, 10.1007/BF01915343 Petkov, 1983, Inhibition of rat heart phosphodiesterase by some rotenoids and isoflavonoids, Planta Med, 47, 237, 10.1055/s-2007-969996 Yamashita, 1990, Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol, Biochem Pharmacol, 39, 737, 10.1016/0006-2952(90)90153-C Okura, 1988, Effect of genistein on topoisomerase activity and on the growth of (Val 12)Ha-ras-transformed NIH 3T3 cells, Biochem Biophys Res Commun, 157, 183, 10.1016/S0006-291X(88)80030-5 Hunter, 1985, Protein tyrosine kinases, Annu Rev Biochem, 54, 897, 10.1146/annurev.bi.54.070185.004341 Bishop, 1983, Cellular oncogenes and retroviruses, Annu Rev Biochem, 52, 301, 10.1146/annurev.bi.52.070183.001505 Ushiro, 1980, Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes, J Biol Chem, 255, 8363, 10.1016/S0021-9258(18)43497-7 Ek, 1982, Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor, Nature, 295, 419, 10.1038/295419a0 Kasuga, 1982, Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system, Nature, 298, 667, 10.1038/298667a0 Jacobs, 1983, Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor, J Biol Chem, 258, 9581, 10.1016/S0021-9258(17)44530-3 Ogawara, 1989, Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones, J Antibiotics, 42, 340, 10.7164/antibiotics.42.340 Spedding, 1989, Inhibition of reverse transcriptases by flavonoids, Antiv Res, 12, 99, 10.1016/0166-3542(89)90073-9 Farriola, 1989, Biochem Pharmacol, 38, 1617, 10.1016/0006-2952(89)90309-2 Bracke, 1991, Effect of catechins and citrus flavonoids on invasion in vitro, Clin Exp Metastasis, 9, 13, 10.1007/BF01831706 Gaitan, 1989, Anti-thyroid and goitrogenic effects of millet: role of c-glycosylflavones, J Clin Endocrinol Metab, 68, 707, 10.1210/jcem-68-4-707 Koehrle, 1986, Iodothyronine deiodinase is inhibited by plant flavonoids, Prog Clin Biol Res, 213, 359 Auf'mkolk, 1986, Inhibition of rat liver iodothyronine deiodinase. Interactions of aurones with the iodothyronine ligand binding site, J Biol Chem, 261, 11623, 10.1016/S0021-9258(18)67288-6 Kohrle, 1987, Metabolism of the thyroid hormones, Horm Res, 26, 58, 10.1159/000180686 Kohrle, 1989, Rapid effects of the flavonoid EMD 21388 on serum hormone binding and thyrotropin regulation in the rat, Endocrinology, 125, 532, 10.1210/endo-125-1-532 Kondo, 1990, BE-14384 substances, new specific estrogen-receptor binding inhibitors. Production, isolation, structure determination and biological properties, J Antibiotics, 43, 1533, 10.7164/antibiotics.43.1533 Martin, 1978, Phytoestrogen interaction with estrogen receptors in human breast cancer cells, Endocrinology, 103, 1860, 10.1210/endo-103-5-1860 Setchell, 1984, Non-steroidal estrogens of dietary origin: possible role in hormone-dependent disease, Am J Clin Nutr, 40, 569, 10.1093/ajcn/40.3.569 Kellis, 1984, Inhibition of human estrogen synthetase (aromatase) by flavones, Science, 225, 1032, 10.1126/science.6474163 Clark, 1978, Heterogeneity of estrogen binding sites in the cytosol of rat uterus, J Biol Chem, 253, 7630, 10.1016/S0021-9258(17)34416-2 Scambia, 1990, Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells, Br J Cancer, 62, 942, 10.1038/bjc.1990.414 Markarevich, 1983, An endogenous inhibitor of [3H]-estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues, Cancer Res, 44, 1575 Carbone, 1989, Type II estrogen receptors in the papillary cystic tumor of the pancreas, Am J Clin Pathol, 92, 572, 10.1093/ajcp/92.5.572 Markarevich, 1983, Preliminary characterization of an endogenous inhibitor of [3H]-estradiol binding in rat uterine nuclei, J Biol Chem, 258, 11663, 10.1016/S0021-9258(17)44279-7 Markarevich, 1990, Methyl-p-hydroxy-phenyllactate and nuclear type II binding sites in malignant cells: metabolic fate and mammary tumor growth, Cancer Res, 50, 1470 Smith, 1992, Bradyrhizobium japonicum nodD1 can be specifically induced by soybean flavonoids that do not induce the nodYABCSUIJ operon, J Biol Chem, 267, 310, 10.1016/S0021-9258(18)48495-5 Kuhnau, 1976, The flavonoids. A class of semi-essential food components: their role in human nutrition, World Rev Nutr Diet, 24, 112 Schimmer, 1986, Flavonoide, Dtsch Apotheker Z, 126, 1811 MacGregor, 1986, Genetic toxicology of dietary flavonoids, Vol 206, 33 Ferrandiz, 1991, Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids, Ag Act, 32, 283, 10.1007/BF01980887 Alcaraz, 1989, Anti-inflammatory activity of natural phenolic compounds, Vol 2, 77 Kenny, 1990, Flavonoid modulation of murine neutrophil citokynesis, Immunopharm Immunotoxicol, 12, 527, 10.3109/08923979009006476 Picq, 1991, Effect of two flavonoid compounds on central nervous system. Analgesic activity, Life Sci, 49, 1979, 10.1016/0024-3205(91)90640-W Kantengwa, 1991, Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis, Biochem Biophys Res Comm, 180, 308, 10.1016/S0006-291X(05)81293-8 De Whalley, 1990, Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages, Biochem Pharmacol, 39, 1743, 10.1016/0006-2952(90)90120-A Larocca, 1990, Type II estrogen binding sites in acute lymphoid and non-lymphoid leukaemias: growth inhibitory effect of oestrogen and flavonoids, Br J Haematol, 75, 489, 10.1111/j.1365-2141.1990.tb07787.x Marvarevich, 1988, Bioflavonoid interaction with rat uterine binding sites and cell growth inhibition, J Steroid Biochem, 30, 71, 10.1016/0022-4731(88)90078-7 Scambia, 1990, Type II estrogen binding sites in a lymphoblastoid cell line and growth inhibitory effect of estrogen, antiestrogen and bioflavonoids, Int J Cancer, 46, 1112, 10.1002/ijc.2910460627 Chang, 1985, Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo(a)pyrene and (+ −)-7β,7α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydro-benzo(α)pyrene on mouse skin and in the newborn mouse, Carcinogenesis, 6, 1127, 10.1093/carcin/6.8.1127 Plowman, 1986, Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice, Cancer Treat Rep, 70, 631 Yamazaki, 1986, Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats, Life Sci, 38, 951, 10.1016/0024-3205(86)90265-1 Yamazaki, 1986, Effect of ipriflavone on osteoporosis induced by ovariectomy in rats, J Bone Miner Metab, 3, 205 Shino, 1986, Effect of ipriflavone on bone and mineral metabolism in the streptozotocin diabetic rats, J Bone Miner Metab, 3, 27 Yoshida, 1985, Disposition of ipriflavone (TC-80) in rats and dogs, Radioisotopes, 34, 618, 10.3769/radioisotopes.34.11_618 Tsuda, 1987, The effect of ipriflavone (TC-80) on bone resorption in tissue culture, J Bone Miner Res, 1, 207, 10.1002/jbmr.5650010207 Suda, 1987, Effect of parathyroid hormone on parietal bones of rats, and effect of ipriflavone, J Bone Miner Metab, 5, 51 Bonucci, 1992, Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats, Calcif Tissue Int, 50, 314, 10.1007/BF00301628 Benvenuti, 1991, Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line, J Bone Miner Res, 6, 987, 10.1002/jbmr.5650060913 Havsteen, 1983, Flavonoids, a class of natural products of high pharmacological potency, Biochem Pharmacol, 32, 1141, 10.1016/0006-2952(83)90262-9 Maxwell, 1992, Identification, purification, and characterization of S-adenosyl-L-methionine: Isoliquiritigenin 2′-O-methyltransferase from alfalfa (Medicago sativa L.), Arch Biochem Biophys, 293, 158, 10.1016/0003-9861(92)90379-B Popp, 1991, Induction of sister-chromatid exchanges (SCE), polyploidy, and micronuclei by plant flavonoids in human lymphocyte cultures. A comparative study of 19 flavonoids, Mutat Res, 246, 205, 10.1016/0027-5107(91)90123-6 Buening, 1981, Activation and inhibition of benzo(a)pyrene and aflatoxin B metabolism in human liver microsomes by naturally occurring flavonoids, Cancer Res, 41, 67 Vernet, 1986, Comparison of the effects of various flavonoids on ethoxycoumarin deethylase activity of rat intestinal and hepatic microsomes, Food Chem Toxicol, 24, 857, 10.1016/0278-6915(86)90077-3 Friedman, 1985, Modulation of rat hepatic aryl hydrocarbon hydroxylase by various flavones and polycyclic aromatic hydrocarbons, Pharmacology, 31, 194, 10.1159/000138115 Thiyagarajah, 1991, Effect of myricetin and other flavonoids on the liver plasma membrane Ca2+ pump, Biochem Pharmacol, 41, 669, 10.1016/0006-2952(91)90065-D Saito, 1985, Pharmacokinetic study of ipriflavone (TC-80) by oral administration in healthy male volunteers, Jpn Pharm Ther J, 13, 7223 Sato, 1986, Pharmacokinetics of ipriflavone tablets in long-term administration to patients with osteoporosis, Jpn Pharm Ther J, 14, 873 Clark, 1978, Heterogeneity of estrogen binding sites in the cytosol of the rat uterus, J Biol Chem, 253, 7630, 10.1016/S0021-9258(17)34416-2 Markaverich, 1988, Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition, J Steroid Biochem, 30, 71, 10.1016/0022-4731(88)90078-7